REPORT FROM THE AAN, APRIL 10-17, 2010 – Several retrospective analyses have suggested that elevated troponin levels at admission are associated with higher mortality rates in patients following intracerebral hemorrhage (ICH) (Garrett et al. Neurocrit Care 2010; 12: 199-203; Hays & Diringer. Neurology 2006; 66: 1330-1334; Chung et al. J Korean Neurosurg Soc 2009; 45: 355-359. Free full text at www.jkns.or.kr/htm/fulltext.asp?no=0042009075).
Neurology
Trichloroethylene associated with PD risk
July 7, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – A population-based study reports that trichloroethylene exposure is a risk factor for the develop of Parkinson’s disease (Goldman et al. AAN, S03.005).
Adjunctive ropinirole in advanced PD
July 7, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – Results of a randomized trial of adjunctive prolonged-release ropinirole indicate that the dopamine agonist may provide better 24-hour symptom control in advanced PD patients treated with L-dopa (Stocchi et al. AAN, S33.003).
Follow-up data of rituximab in SPMS
June 23, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – A small retrospective study has examined the long-term effects of rituximab, a monoclonal antibody directed against CD20+ B cells, in patients with secondary-progressive MS (Ionete et al. AAN, P02.147).
FDG-PET useful in differential diagnosis of dementia
June 23, 2010REPORT FROM THE AAN, APRIL 10-17, 2010 – A Canadian retrospective study has examined the potential usefulness of [18F]-fluorodeoxyglucose PET (FDG-PET) in the diagnosis of atypical or unclear dementias (Laforce et al. AAN P03.020).